geoopen
A third generation therapeutic vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: first-in-human trial of ChAd63-KH
GEO Series GSE98212. Homo sapiens. 50 samples. Type: Expression profiling by high throughput sequencing.
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8